Skip to NavigationSkip to content

News

0
Roche has unveiled new data for its antibody-drug conjugate Kadcyla (trastuzumab emtansine) in the treatment of patients with HER2-positive early...
0
Swiss multinational Novartis have joined German pharma firm Bayer in appealing a High Court ruling over 12 NHS clinical commissioning groups (CCGs...
0
US Health and Human Services Secretary Alex Azar, has announced a proposal which would require pharma firms to include the list price of any drug...
0
Amgen has announced the launch of a proprietary biosimilar version of its best-selling drug Humira (adalimumab) across all European markets,...

Features

They’re two of the biggest buzzwords getting professionals excited across pharma – Anjali Shukla explores the ways in which AI and big data are...